OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A biological rationale for the disparate effects of omega-3 fatty acids on cardiovascular disease outcomes
Samuel Sherratt, Peter Libby, Deepak L. Bhatt, et al.
Prostaglandins Leukotrienes and Essential Fatty Acids (2022) Vol. 182, pp. 102450-102450
Open Access | Times Cited: 26
Samuel Sherratt, Peter Libby, Deepak L. Bhatt, et al.
Prostaglandins Leukotrienes and Essential Fatty Acids (2022) Vol. 182, pp. 102450-102450
Open Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues
Samuel Sherratt, Peter Libby, Matthew J. Budoff, et al.
Current Atherosclerosis Reports (2022) Vol. 25, Iss. 1, pp. 1-17
Open Access | Times Cited: 77
Samuel Sherratt, Peter Libby, Matthew J. Budoff, et al.
Current Atherosclerosis Reports (2022) Vol. 25, Iss. 1, pp. 1-17
Open Access | Times Cited: 77
Do patients benefit from omega-3 fatty acids?
Samuel Sherratt, R. Preston Mason, Peter Libby, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 18, pp. 2884-2901
Open Access | Times Cited: 26
Samuel Sherratt, R. Preston Mason, Peter Libby, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 18, pp. 2884-2901
Open Access | Times Cited: 26
Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low‐Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE‐IT Randomized Trial
Rahul Aggarwal, Deepak L. Bhatt, Philippe Gabríel Steg, et al.
Journal of the American Heart Association (2025)
Open Access | Times Cited: 1
Rahul Aggarwal, Deepak L. Bhatt, Philippe Gabríel Steg, et al.
Journal of the American Heart Association (2025)
Open Access | Times Cited: 1
Clinical Trial Design for Triglyceride-Rich Lipoprotein-Lowering Therapies
Waqas Malick, Ori Waksman, Ron Do, et al.
Journal of the American College of Cardiology (2023) Vol. 81, Iss. 16, pp. 1646-1658
Open Access | Times Cited: 20
Waqas Malick, Ori Waksman, Ron Do, et al.
Journal of the American College of Cardiology (2023) Vol. 81, Iss. 16, pp. 1646-1658
Open Access | Times Cited: 20
Severe hypertriglyceridemia: Existing and emerging therapies
Waqas Malick, Ron Do, Robert S. Rosenson
Pharmacology & Therapeutics (2023) Vol. 251, pp. 108544-108544
Closed Access | Times Cited: 17
Waqas Malick, Ron Do, Robert S. Rosenson
Pharmacology & Therapeutics (2023) Vol. 251, pp. 108544-108544
Closed Access | Times Cited: 17
Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis
Monica Dinu, Francesco Sofi, Sofia Lotti, et al.
European Journal of Preventive Cardiology (2024)
Open Access | Times Cited: 8
Monica Dinu, Francesco Sofi, Sofia Lotti, et al.
European Journal of Preventive Cardiology (2024)
Open Access | Times Cited: 8
Novel therapeutic approaches in thalassemias, sickle cell disease, and other red cell disorders
Valeria Maria Pinto, Filippo Mazzi, Lucia De Franceschi
Blood (2024) Vol. 144, Iss. 8, pp. 853-866
Open Access | Times Cited: 7
Valeria Maria Pinto, Filippo Mazzi, Lucia De Franceschi
Blood (2024) Vol. 144, Iss. 8, pp. 853-866
Open Access | Times Cited: 7
Omega-3 and cardiovascular prevention – Is this still a choice?
Massimiliano Ruscica, Cesare R. Sirtori, Stefano Carugo, et al.
Pharmacological Research (2022) Vol. 182, pp. 106342-106342
Open Access | Times Cited: 23
Massimiliano Ruscica, Cesare R. Sirtori, Stefano Carugo, et al.
Pharmacological Research (2022) Vol. 182, pp. 106342-106342
Open Access | Times Cited: 23
Frontiers and hotspots evolution in anti-inflammatory studies for coronary heart disease: A bibliometric analysis of 1990–2022
Jiale Zhang, Chenyang Ji, Xu Zhai, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 16
Jiale Zhang, Chenyang Ji, Xu Zhai, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 16
Assessing Omega-3 Therapy and Its Cardiovascular Benefits: What About Icosapent Ethyl? A Systematic Review and Meta-Analysis
Nathália Mendes Machado, Maria Júlia Ribeiro de Oliveira, Karina Quesada, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 601-601
Open Access
Nathália Mendes Machado, Maria Júlia Ribeiro de Oliveira, Karina Quesada, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 601-601
Open Access
VLDL receptor gene therapy for reducing atherogenic lipoproteins
Ronald M. Krauss, Jonathan T. Lu, Joseph Higgins, et al.
Molecular Metabolism (2023) Vol. 69, pp. 101685-101685
Open Access | Times Cited: 8
Ronald M. Krauss, Jonathan T. Lu, Joseph Higgins, et al.
Molecular Metabolism (2023) Vol. 69, pp. 101685-101685
Open Access | Times Cited: 8
A Critical Review of Icosapent Ethyl in Cardiovascular Risk Reduction
Jessica Huston, Hannah Schaffner, Alyssa Cox, et al.
American Journal of Cardiovascular Drugs (2023) Vol. 23, Iss. 4, pp. 393-406
Open Access | Times Cited: 7
Jessica Huston, Hannah Schaffner, Alyssa Cox, et al.
American Journal of Cardiovascular Drugs (2023) Vol. 23, Iss. 4, pp. 393-406
Open Access | Times Cited: 7
Integrating Network Pharmacology and Metabolomics to Explore the Potential Mechanism of Pinolenic Acid against Atherosclerosis
Zhanhong Cao, Zhuang Zhang, Qing Yang, et al.
Journal of Food Biochemistry (2024) Vol. 2024, pp. 1-14
Open Access | Times Cited: 2
Zhanhong Cao, Zhuang Zhang, Qing Yang, et al.
Journal of Food Biochemistry (2024) Vol. 2024, pp. 1-14
Open Access | Times Cited: 2
5,6-diHETE lactone (EPA-L) mediates hypertensive microvascular dilation by activating the endothelial GPR-PLC-IP3 signaling pathway
Meitar Asulin, Nadav Gorodetzer, Rotem Fridman, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 700, pp. 149585-149585
Closed Access | Times Cited: 2
Meitar Asulin, Nadav Gorodetzer, Rotem Fridman, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 700, pp. 149585-149585
Closed Access | Times Cited: 2
Icosapent ethyl modulates circulating vascular regenerative cell content: The IPE-PREVENTION CardioLink-14 trial
Ehab Bakbak, Aishwarya Krishnaraj, Deepak L. Bhatt, et al.
Med (2024) Vol. 5, Iss. 7, pp. 718-734.e4
Closed Access | Times Cited: 2
Ehab Bakbak, Aishwarya Krishnaraj, Deepak L. Bhatt, et al.
Med (2024) Vol. 5, Iss. 7, pp. 718-734.e4
Closed Access | Times Cited: 2
Omega‐3 polyunsaturated fatty acids and pulmonary arterial hypertension: Insights and perspectives
Marika Massaro, Stefano Quarta, Nadia Calabriso, et al.
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 11
Closed Access | Times Cited: 2
Marika Massaro, Stefano Quarta, Nadia Calabriso, et al.
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 11
Closed Access | Times Cited: 2
EPA and DHA inhibit LDL-induced upregulation of human adipose tissue NLRP3 inflammasome/IL-1β pathway and its association with diabetes risk factors
Valérie Lamantia, Simon Bissonnette, Myriam Beaudry, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Valérie Lamantia, Simon Bissonnette, Myriam Beaudry, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Long-Chain Omega-3 Fatty Acid Supplementation and Exercise-Induced Muscle Damage: EPA or DHA?
Jeffery L. Heileson, Dillon R. Harris, Sara Tomek, et al.
Medicine & Science in Sports & Exercise (2023) Vol. 56, Iss. 3, pp. 476-485
Closed Access | Times Cited: 6
Jeffery L. Heileson, Dillon R. Harris, Sara Tomek, et al.
Medicine & Science in Sports & Exercise (2023) Vol. 56, Iss. 3, pp. 476-485
Closed Access | Times Cited: 6
ω‑3 fatty acids in atherosclerotic cardiovascular disease (Review)
Xingxing Xie, Xue Liu, Rong Li, et al.
Biomedical Reports (2024) Vol. 20, Iss. 6
Open Access | Times Cited: 1
Xingxing Xie, Xue Liu, Rong Li, et al.
Biomedical Reports (2024) Vol. 20, Iss. 6
Open Access | Times Cited: 1
Saturated fatty acids negatively affect musculoskeletal tissues in vitro and in vivo
Ryan T. Lin, Benjamin Osipov, Danielle Steffen, et al.
Matrix Biology Plus (2024) Vol. 23, pp. 100153-100153
Open Access | Times Cited: 1
Ryan T. Lin, Benjamin Osipov, Danielle Steffen, et al.
Matrix Biology Plus (2024) Vol. 23, pp. 100153-100153
Open Access | Times Cited: 1
The Anti-Aggregative Potential of Resolvin E1 on Human Platelets
Patrycja Szymańska, Bogusława Luzak, Katarzyna Miłowska, et al.
Molecules (2023) Vol. 28, Iss. 14, pp. 5323-5323
Open Access | Times Cited: 3
Patrycja Szymańska, Bogusława Luzak, Katarzyna Miłowska, et al.
Molecules (2023) Vol. 28, Iss. 14, pp. 5323-5323
Open Access | Times Cited: 3
Update About the Management of Low-Density Lipoprotein Cholesterol and Hypertriglyceridemia in Lower Extremity Peripheral Artery Disease Patients: Consensus of the French Society of Vascular Medicine and the French Society for Vascular and Endovascular Surgery
Guillaume Mahé, G. Böge, A. Bura-Rivière, et al.
Annals of Vascular Surgery (2023)
Closed Access | Times Cited: 1
Guillaume Mahé, G. Böge, A. Bura-Rivière, et al.
Annals of Vascular Surgery (2023)
Closed Access | Times Cited: 1
EPA and DHA inhibit LDL-induced upregulation of human adipose tissue NLRP3 inflammasome/IL-1β pathway and its association with diabetes risk factors
Valérie Lamantia, Simon Bissonnette, Myriam Beaudry, et al.
Research Square (Research Square) (2024)
Open Access
Valérie Lamantia, Simon Bissonnette, Myriam Beaudry, et al.
Research Square (Research Square) (2024)
Open Access
Omega-3 supplementation: Impact on Low Chronic Inflammation Associated with Obesity
Emilio López-Millán, Janet A. Gutiérrez‐Uribe, Marilena Antunes‐Ricardo
Trends in Food Science & Technology (2024), pp. 104799-104799
Closed Access
Emilio López-Millán, Janet A. Gutiérrez‐Uribe, Marilena Antunes‐Ricardo
Trends in Food Science & Technology (2024), pp. 104799-104799
Closed Access
Epeleuton, a novel synthetic ω-3 fatty acid, reduces the hypoxia/reperfusion stress in a mouse model of sickle cell disease
Alessandro Mattè, Enrica Federti, Antonio Recchiuti, et al.
Haematologica (2023)
Open Access
Alessandro Mattè, Enrica Federti, Antonio Recchiuti, et al.
Haematologica (2023)
Open Access
